Literature DB >> 7715338

Is measles vaccination a risk factor for inflammatory bowel disease?

N P Thompson1, S M Montgomery, R E Pounder, A J Wakefield.   

Abstract

Measles virus may persist in intestinal tissue, particularly that affected by Crohn's disease, and early exposure to measles may be a risk factor for the development of Crohn's disease. Crohn's disease and ulcerative colitis occur in the same families and may share a common aetiology. In view of the rising incidence of inflammatory bowel disease (Crohn's disease and ulcerative colitis), we examined the impact of measles vaccination upon these conditions. Prevalences of Crohn's disease, ulcerative colitis, coeliac disease, and peptic ulceration were determined in 3545 people who had received live measles vaccine in 1964 as part of a measles vaccine trial. A longitudinal birth cohort of 11,407 subjects was one unvaccinated comparison cohort, and 2541 partners of those vaccinated was another. Compared with the birth cohort, the relative risk of developing Crohn's disease in the vaccinated group was 3.01 (95% CI 1.45-6.23) and of developing ulcerative colitis was 2.53 (1.15-5.58). There was no significant difference between these two groups in coeliac disease prevalence. Increased prevalence of inflammatory bowel disease, but not coeliac disease or peptic ulceration, was found in the vaccinated cohort compared with their partners. These findings suggest that measles virus may play a part in the development not only of Crohn's disease but also of ulcerative colitis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7715338     DOI: 10.1016/s0140-6736(95)90816-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  40 in total

1.  No evidence of persistent mumps virus infection in inflammatory bowel disease.

Authors:  M Iizuka; H Saito; M Yukawa; H Itou; T Shirasaka; M Chiba; T Fukushima; S Watanabe
Journal:  Gut       Date:  2001-05       Impact factor: 23.059

2.  Inflammatory bowel disease: definition, epidemiology, etiologic aspects, and immunogenetic studies.

Authors:  Bing Xia; JBA Crusius; SGM Meuwissen; AS Pe?a
Journal:  World J Gastroenterol       Date:  1998-10       Impact factor: 5.742

3.  MMR vaccine--worries are not justified.

Authors:  D A Elliman; H E Bedford
Journal:  Arch Dis Child       Date:  2001-10       Impact factor: 3.791

Review 4.  Detection of persistent measles virus infection in Crohn's disease: current status of experimental work.

Authors:  S Ghosh; E Armitage; D Wilson; P D Minor; M A Afzal
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

5.  Measles virus serology in Crohn's disease.

Authors:  N C Fisher; L Yee; P Nightingale; R McEwan; J A Gibson
Journal:  Gut       Date:  1997-07       Impact factor: 23.059

6.  MMR vaccine and Crohn's disease: ecological study of hospital admissions in England, 1991 to 2002.

Authors:  Valerie Seagroatt
Journal:  BMJ       Date:  2005-04-18

Review 7.  Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.

Authors:  J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

8.  Treatment of ulcerative colitis in the cottontop tamarin using antibody to tumour necrosis factor alpha.

Authors:  P E Watkins; B F Warren; S Stephens; P Ward; R Foulkes
Journal:  Gut       Date:  1997-05       Impact factor: 23.059

Review 9.  MMR: where are we now?

Authors:  David Elliman; Helen Bedford
Journal:  Arch Dis Child       Date:  2007-07-11       Impact factor: 3.791

Review 10.  Hygiene hypothesis in inflammatory bowel disease: a critical review of the literature.

Authors:  Natasha-A Koloski; Laurel Bret; Graham Radford-Smith
Journal:  World J Gastroenterol       Date:  2008-01-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.